• LAST PRICE
    0.1850
  • TODAY'S CHANGE (%)
    Trending Up0.0063 (3.4965%)
  • Bid / Lots
    0.1600/ 50
  • Ask / Lots
    0.1850/ 50
  • Open / Previous Close
    0.1850 / 0.1788
  • Day Range
    Low 0.1600
    High 0.1850
  • 52 Week Range
    Low 0.0640
    High 0.2465
  • Volume
    5,400
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.17875
TimeVolumeGTHP
10:13 ET50000.16
10:27 ET4000.185
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGTHP
Guided Therapeutics Inc
11.3M
-4.3x
---
United StatesBINP
Bionoid Pharma Inc
10.8M
0.2x
---
United StatesALRTF
ALR Technologies Inc
9.0M
-1.0x
---
United StatesAMIX
Autonomix Medical Inc
7.2M
-0.4x
---
United StatesKLYG
Kelyniam Global Inc
6.4M
-8.3x
---
United StatesCSOC
Caduceus Software Systems Corp
5.6M
-17.9x
---
As of 2024-11-23

Company Information

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.

Contact Information

Headquarters
Suite 300, 4955 Avalon Ridge PkwyNORCROSS, GA, United States 30071
Phone
770-242-8723
Fax
770-242-8639

Executives

Independent Chairman of the Board
Michael James
President, Chief Executive Officer, Acting Chief Financial Officer, Chief Operating Officer, Director
Mark Faupel
Acting Chief Financial Officer
Gene Cartwright
Director
Richard Blumberg
Director
Alan Grujic

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$11.3M
Revenue (TTM)
$38.0K
Shares Outstanding
61.0M
Guided Therapeutics Inc does not pay a dividend.
Beta
0.49
EPS
$-0.04
Book Value
$-0.07
P/E Ratio
-4.3x
Price/Sales (TTM)
297.0
Price/Cash Flow (TTM)
---
Operating Margin
-4,957.90%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.